InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Discover the detailed record of transactions filed by BURWIG SUSAN E, Exec. VP, Operations. Insider active across 1 companies, notably Medpace Holdings, Inc.. Aggregated, 7 filings have been recorded. Total volume traded: €19.9m. The latest transaction was disclosed on 27 October 2025 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
US$1m2,000 shares@ US$520.139210.3% of flow
Common Stock
SEC:0001677418-25-000010·
€1m2,000 shares@ €520.13920.0065% mcap5.1% of flow
Common Stock
SEC:0001677418-25-000010:0·
€309,96912,400 shares@ €24.99750.0019% mcap1.5% of flow
Common Stock
SEC:0001567619-22-005628:0·
€9m55,037 shares@ €161.798788.3% of flow
Common Stock
SEC:0001567619-21-016795·
€9m55,037 shares@ €161.79870.056% mcap43.5% of flow
Common Stock
SEC:0001567619-21-016795:0·
€140,4037,400 shares@ €18.97341.4% of flow
Common Stock
SEC:0001567619-21-012190·
€140,4037,400 shares@ €18.97340.0009% mcap0.7% of flow
Common Stock
SEC:0001567619-21-012190:0·
7 of 7 declarations
About BURWIG SUSAN E
Susan E. Burwig is the Executive Vice President of Operations at Medpace Holdings, Inc. In this role, she oversees the company's operations, ensuring efficiency and quality of services. Her expertise in the clinical trials sector is essential in optimizing operational processes. With a strong management background, she contributes to strategic decision-making.
